Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine

A 62-year-old woman who underwent surgery to treat pancreatic cancer provided written, informed consent to undergo adjuvant therapy with gemcitabine, tegafur, and uracil. However, this was stopped after only 14 days due to Grade 4 neutropenia. She was then started on vaccine therapy with Survivin 2B...

Descripción completa

Detalles Bibliográficos
Autores principales: Shima, Hiroaki, Kutomi, Goro, Satomi, Fukino, Imamura, Masafumi, Kimura, Yasutoshi, Mizuguchi, Toru, Watanabe, Kazue, Takahashi, Akari, Murai, Aiko, Tsukahara, Tomohide, Kanaseki, Takayuki, Hirohashi, Yoshihiko, Iwayama, Yuji, Tsuruma, Tetsuhiro, Kameshima, Hidekazu, Sato, Noriyuki, Torigoe, Toshihiko, Takemasa, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182403/
https://www.ncbi.nlm.nih.gov/pubmed/30069687
http://dx.doi.org/10.1007/s00262-018-2217-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182403/
https://www.ncbi.nlm.nih.gov/pubmed/30069687
http://dx.doi.org/10.1007/s00262-018-2217-x

Ejemplares similares